CLEC14A was up-regulated in hepatocellular carcinoma and may function as a potential diagnostic biomarker. Clinics [Internet]. 2022 May 14 [cited 2024 Jun. 15];77:100029. Available from: https://www.journals.usp.br/clinics/article/view/213315